BTG plc (LON:BTG) had its price objective boosted by stock analysts at JPMorgan Chase & Co. from GBX 790 ($10.31) to GBX 830 ($10.83) in a research report issued to clients and investors on Friday. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s target price points to a potential upside of 21.35% from the stock’s current price.

A number of other brokerages have also recently weighed in on BTG. Numis Securities Ltd restated a “hold” rating and set a GBX 737 ($9.62) price objective on shares of BTG plc in a research note on Thursday. Deutsche Bank AG reaffirmed a “buy” rating on shares of BTG plc in a research report on Thursday, September 8th. Jefferies Group reaffirmed a “buy” rating and set a GBX 860 ($11.23) target price on shares of BTG plc in a research report on Friday, July 15th. Finally, Stifel Nicolaus reaffirmed a “buy” rating on shares of BTG plc in a research report on Friday, June 24th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of GBX 799.57 ($10.44).

Analyst Recommendations for BTG plc (LON:BTG)

BTG plc (LON:BTG) opened at 684.00 on Friday. The stock’s market capitalization is GBX 2.62 billion. BTG plc has a 52-week low of GBX 504.00 and a 52-week high of GBX 739.50. The stock’s 50 day moving average price is GBX 627.97 and its 200-day moving average price is GBX 640.80.

In other news, insider Soderstrom,Rolf sold 74,327 shares of the stock in a transaction dated Thursday, July 21st. The stock was sold at an average price of GBX 676 ($8.82), for a total value of £502,450.52 ($655,855.01).

About BTG plc

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.

Receive News & Stock Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related stocks with our FREE daily email newsletter.